- Home
- Equipment
- north america
- oncology therapy
Refine by
Oncology Therapy Equipment Supplied In North America
12 equipment items found
Manufactured by:Saladax Biomedical, Inc. based inBethlehem, PENNSYLVANIA (USA)
Neutropenia and neuropathy can be serious side-effects associated with paclitaxel chemotherapy. While hematological toxicities can be addressed, there is no good solution for chemotherapy induced peripheral neuropathy, which is frequent, may be debilitating and can persist or appear after ...
Manufactured by:Saladax Biomedical, Inc. based inBethlehem, PENNSYLVANIA (USA)
Targeted therapies are revolutionizing oncology. Patients with chronic myeloid leukemia treated with the tyrosine kinase inhibitors (TKI) now have life expectancies approaching that of the general population. Imatinib (Gleevec®, Gilvec®) the first TKI approved has substantial efficacy in chronic myeloid leukemia (CML) and gastrointestinal stromal ...
Manufactured by:Saladax Biomedical, Inc. based inBethlehem, PENNSYLVANIA (USA)
BSA dosing results in sub-target 5-FU levels in the majority of patients. PK- guided dosing can move 5-FU levels into the target range. Optimal dosing of 5-FU is associated with increased efficacy and reduced ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Tarlatamab has the KDs of 14.9 nM and 12 nM for human and NHP CD3, respectively. Tarlatamab is a first-in-class HLE BiTE immuno-oncology therapy targeting DLL3 and has the potential for SCLC ...
Manufactured by:Gilead based inFoster City, CALIFORNIA (USA)
Sacituzumab govitecan-hziy 180 mg for injection. ...
Manufactured by:Gilead based inFoster City, CALIFORNIA (USA)
Brexucabtagene autoleucel . TECARTUS.TECARTUS®(brexucabtagene autoleucel)suspension for intravenous infusion. ...
Manufactured by:Philips Healthcare based inAmsterdam, NETHERLANDS
Supported by rigorous clinical evidence, Vereos is the world’s first and only fully digital, clinically proven, PET/CT solution . With proprietary Digital Photon Counting technology for outstanding advances all along the imaging chain, Vereos exemplifies an established total solution to reveal more, earlier, to help you improve patient care and manage ...
Manufactured by:Keller Technology Corporation (KTC) based inTonawanda, NEW YORK (USA)
Keller provides medical device and equipment manufacturing for imaging and radio oncology including proton therapy, linac delivered radiotherapy, PET and MRI. We bring expertise in cGMP regulatory environments. Projects include accelerator, cyclotron and magnet-based equipment for imaging or therapeutic ...
Manufactured by:Theriva Biologics, Inc., formely known as ynthetic Biologics, Inc. based inRockville, MARYLAND (USA)
Building on the clinical advancement of VCN-01, Theriva developed the Albumin Shield™ technology to protect oncolytic viruses from circulating anti-oncolytic virus antibodies after systemic administration. We anticipate that this technology will enable multiple oncolytic virus doses to be administered in therapeutic cycles to treat particularly refractory ...
Manufactured by:Lupagen Inc. based inDallas, TEXAS (USA)
Lupagen avoids the cost & complexity of cell therapy and the safety & clinical challenges of viral-based gene therapy by a simple patient-connected gene delivery procedure done at the bedside. Our Side CAR-T® delivery system, a first-in-class bedside system enables gene delivery directly to target cells in a highly-controlled and safe environment before reinfusing therapies to the ...
Manufactured by:AllCells based inAlameda, CALIFORNIA (USA)
Leukopaks are enriched leukapheresis products collected from healthy and consenting donors using the Spectra Optia® Apheresis System following an IRB-approved protocol. Leukopaks typically contain up to 50% T cells, 20% monocytes, 10% B cells, 10% NK cells, 3% granulocytes, and 3% hematocrit. Leukapheresis results in high yields of single-donor mononuclear cells (MNCs) compared to ...
Manufactured by:AllCells based inAlameda, CALIFORNIA (USA)
Hematopoietic stem and progenitor cells (HSPCs) are the key stem cell population in the bone marrow capable of self-renewal and multilineage differentiation into mature blood cell types. CD34+ HSPCs can be isolated from mobilized peripheral blood, bone marrow, and umbilical cord blood. Clinical HSPC transplantation is used to treat blood cancers (leukemia, myeloma and lymphomas), autoimmune ...